• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying

    7/19/24 1:17:07 PM ET
    $ADVM
    $APPN
    $NYC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADVM alert in real time by email

    Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform.

    Adverum Biotechnologies

    • The Trade: Adverum Biotechnologies, Inc. (NASDAQ:ADVM) 10% owner Braden Michael Leonard acquired a total of 216,264 shares at an average price of $8.26. To acquire these shares, it cost around $1.79 million.
    • What's Happening: On July 17, Adverum Biotechnologies released data from its ongoing LUNA Phase 2 trial for Ixo-vec in patients with wet age-related macular degeneration (AMD).
    • What Adverum Biotechnologies Does: Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company.

    Appian

    • The Trade: Appian Corporation (NASDAQ:APPN) 10% owner Colin T. Moran acquired a total of 300,000 shares at </em></a> an average price of $35.40. To acquire these shares, it cost around $10.6 million.
    • What's Happening: Appian will release financial results for the second quarter, before the opening bell on Thursday, Aug. 1.
    • What Appian Does: Appian is a low-code enterprise platform-as-a-service company focusing on business process management.

    American Strategic Investment

    • The Trade: American Strategic Investment Co. (NYSE:NYC) 10% owner New York City Advisors, LLC bought a total of 125,864 shares at an average price of $10.98. To acquire these shares, it cost around $1.38 million.
    • What's Happening: On May 10, the company posted downbeat quarterly sales.
    • What American Strategic Investment Does: American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan.

    Read Next:

    • Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday
    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $APPN
    $NYC

    CompanyDatePrice TargetRatingAnalyst
    Appian Corporation
    $APPN
    1/12/2026$45.00Equal-Weight → Overweight
    Morgan Stanley
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    Appian Corporation
    $APPN
    11/7/2025$38.00Neutral
    DA Davidson
    Appian Corporation
    $APPN
    8/8/2025$30.00Neutral
    DA Davidson
    Appian Corporation
    $APPN
    1/14/2025Sector Weight
    KeyBanc Capital Markets
    Appian Corporation
    $APPN
    1/6/2025$37.00Sector Perform
    Scotiabank
    Appian Corporation
    $APPN
    8/2/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    Appian Corporation
    $APPN
    8/1/2024Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $ADVM
    $APPN
    $NYC
    SEC Filings

    View All

    SEC Form NT 10-K filed by American Strategic Investment Co.

    NT 10-K - American Strategic Investment Co. (0001595527) (Filer)

    4/1/26 6:01:21 AM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Appian Corporation

    SCHEDULE 13G/A - APPIAN CORP (0001441683) (Subject)

    3/26/26 1:49:30 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    American Strategic Investment Co. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - American Strategic Investment Co. (0001595527) (Filer)

    3/26/26 6:01:32 AM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    $ADVM
    $APPN
    $NYC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Link David Forrest

    4 - APPIAN CORP (0001441683) (Issuer)

    4/2/26 4:12:26 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Mccarthy William D.

    4 - APPIAN CORP (0001441683) (Issuer)

    4/2/26 4:12:02 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Lynch Mark Steven

    4 - APPIAN CORP (0001441683) (Issuer)

    4/2/26 4:11:41 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APPN
    $NYC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Appian upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Appian from Equal-Weight to Overweight and set a new price target of $45.00

    1/12/26 7:37:33 AM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    DA Davidson resumed coverage on Appian with a new price target

    DA Davidson resumed coverage of Appian with a rating of Neutral and set a new price target of $38.00

    11/7/25 7:56:55 AM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APPN
    $NYC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    American Strategic Investment Co. Updates Date for Fourth Quarter and Full Year 2025 Results

    American Strategic Investment Co. (NYSE:NYC) ("ASIC" or the "Company") announced today it has rescheduled the date of its previously announced earnings release and call. The Company expects to release its financial results for the fourth quarter and year ended December 31, 2025, on Tuesday, April 14, 2026. The change of date for the release of fourth quarter and full year 2025 financial results and the related webcast is intended to allow additional time to complete customary year-end financial reporting and internal review processes, including finalization of the Company's Annual Report on Form 10‑K. The Company and its recently appointed independent registered public accounting firm are

    3/25/26 5:30:00 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    American Strategic Investment Co. Announces Release Date for Fourth Quarter and Full Year 2025 Results

    - Company to Host Webcast and Call - American Strategic Investment Co. (NYSE:NYC) ("ASIC" or the "Company") announced today it will release its financial results as of, and for the fourth quarter and year ended December 31, 2025, on Thursday March 26, 2026, before the New York Stock Exchange open. The Company will also host a webcast and conference call the same day at 11:00 a.m. ET to review results and provide commentary on business performance. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through the Company's website, http://www.americ

    3/9/26 6:00:00 AM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    Appian Corporation to Present at the Morgan Stanley Technology, Media & Telecom Conference

    MCLEAN, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN), today announced that Serge Tanjga, Chief Financial Officer, will present at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco, CA. The fireside chat is scheduled for Monday, March 2, 2026 at 12:20pm Pacific Time and will be webcast live at the following link: https://cc.webcasts.com/ Replays of the fireside chat will be available for a limited time under the "News and Events" section of the Company's investor relations website at http://investors.appian.com. About AppianAppian provides process automation technology. We automate complex processes in large enterprises and governments. Our platform

    2/24/26 4:05:00 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APPN
    $NYC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Schorsch Nicholas S bought $19,269 worth of shares (1,664 units at $11.58) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    2/2/26 9:31:35 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    Large owner Schorsch Nicholas S bought $55,594 worth of shares (4,992 units at $11.14) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    1/29/26 9:11:35 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    Large owner Schorsch Nicholas S bought $57,726 worth of shares (5,460 units at $10.57) (SEC Form 4)

    4 - American Strategic Investment Co. (0001595527) (Issuer)

    1/23/26 9:52:11 PM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    $ADVM
    $APPN
    $NYC
    Financials

    Live finance-specific insights

    View All

    American Strategic Investment Co. Announces Release Date for Fourth Quarter and Full Year 2025 Results

    - Company to Host Webcast and Call - American Strategic Investment Co. (NYSE:NYC) ("ASIC" or the "Company") announced today it will release its financial results as of, and for the fourth quarter and year ended December 31, 2025, on Thursday March 26, 2026, before the New York Stock Exchange open. The Company will also host a webcast and conference call the same day at 11:00 a.m. ET to review results and provide commentary on business performance. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through the Company's website, http://www.americ

    3/9/26 6:00:00 AM ET
    $NYC
    Real Estate Investment Trusts
    Real Estate

    Appian Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter cloud subscriptions revenue increased 18% year-over-year to $117.0 millionFull year cloud subscriptions revenue increased 19% year-over year to $437.4 million MCLEAN, Va., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announced financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights: Revenue: Cloud subscriptions revenue was $117.0 million, up 18% compared to the fourth quarter of 2024. Total subscriptions revenue, which includes sales of our cloud subscriptions, license subscriptions, and maintenance and support, increased 19% year-over-year to $162.3 million. Professional services revenue was

    2/19/26 7:05:00 AM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    Appian To Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

    MCLEAN, Va., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2025, before the U.S. financial markets open on Thursday, February 19, 2026. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this Registration Link. Once registered, participants can join the call, using their phone with a dial in and PIN. The conference call will also be available live via webcast on the Investor Relations page of the Com

    1/29/26 4:05:00 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APPN
    $NYC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:40:56 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 4:05:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $APPN
    $NYC
    Leadership Updates

    Live Leadership Updates

    View All

    Appian Appoints David Link to Board of Directors

    MCLEAN, Va., Jan. 21, 2026 /PRNewswire/ -- Appian (NASDAQ:APPN) a leader in AI-powered process automation, announced the appointment of David Link to the Appian Board of Directors effective January 25, 2026. Appian announces the appointment of David Link to the Appian Board of Directors effective January 25, 2026.Mr. Link is the Co-Founder and CEO of ScienceLogic, a global leader in AI-driven IT operations, unifying service-centric observability with intelligent automation. Throughout his career, he has worked to solve complex operational challenges facing IT organizations by

    1/21/26 9:30:00 AM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Appian Appoints New Leader of Global Partnerships & Alliances

    MCLEAN, Va., Aug. 25, 2025 /PRNewswire/ -- Appian (NASDAQ:APPN), the leading platform for AI process automation, today announced the appointment of Scott Van Valkenburgh as Senior Vice President, Global Partnerships & Alliances. Appian announces the appointment of Scott Van Valkenburgh as Senior Vice President, Global Partnerships & Alliances.Van Valkenburgh has 25+ years of experience driving revenue growth and market expansion as a Global Alliances & Channels executive and former Big 4 Consulting Principal. He built and managed revenue streams totalling over a billion dollar

    8/25/25 1:23:00 PM ET
    $APPN
    Computer Software: Prepackaged Software
    Technology